Welltheory receives $5 million to introduce new AI tools to support autoimmune care
The company announced Thursday that it has raised $5 million in funding, which has raised $5 million and launched two new AI tools, and Welltheory has raised $5 million.
Well Theyory, based in Atherton, California, treats autoimmune conditions such as Addison’s disease, celiac disease, multiple sclerosis, and lupus. Using a collaborative care model, IT works with the patient’s doctors to provide personalized plans for nutrition, stress, sleep and exercise. The company offers video conferencing, unlimited expert messaging and diagnosis. It serves employers and health plans.
The $5 million raise includes support from new investors Samsung, Opal Venture Capital and UP2 Fund, as well as existing investor acceleration, OVO Fund and Box Group. The company raised a total of $12 million.
The announcement said the financing will help the company expand the employer and health program market and “accelerate the development of AI-driven care infrastructure for providers and members.”
Welltheory also announced the launch of two AI tools: Care Scribe and Care Hub. Care Scribe transcribes membership meetings, draft follow-up notes and develop reviewed care plans, and can be customized by the provider. Meanwhile, Care Hub aggregates member data, session history, and lab insights and places it in one place.
“Care delivery for patients with autoimmune diseases is very complex – our team has built these tools to help our care team get back to the most important time: supporting our members,” Claire Rudolph, co-founder and head of product at Well Theateory, said in a statement. “With Well Theory’s nursing hub and nursing scribe, we have been building modern infrastructure for automated immune care – intelligent, integrated systems that simplify repetitive tasks, expand the reasons for Care whum, and enable our team to deliver more personalized response support at scale.”
The funding and AI announcement comes after Welltheory shared its results report on its model last month. The company’s model has resulted in 81% of members reporting improved digestive symptoms, 55% reported improvement in fatigue, and 45% reported improvement in pain.
Well Theyory was inspired by the experience of CEO and co-founder Ellen Rudolph in search of his own autoimmune condition. She experienced an unexplained list of symptoms including brain fog, gastrointestinal problems and fatigue and was bedridden at the age of 25. She was fired by various doctors until she finally found the answer through some lab results. She eventually went on to build good theories to help others face similar challenges.
In a recent interview at the Health Conference, Rudolph shared that the company’s upcoming priorities include partnerships and health programs with employers, investing in AI and reducing the administrative tasks of providers. Additionally, the company hopes to create a new health plan similar to the women’s health plan for hormonal diseases launched in December.
“We see a lot of comorbidities or some sort of overlapping condition set because of the lack of better words. So, there will definitely be more coming there,” she said.
Images: Feodora Chiosea, Getty Images
